Organicell Regenerative Medicine (OCEL) Stock Highlights

1.15 | +13.86%

2024-12-21 07:36:13

Organicell Regenerative Medicine Inc is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases. Its product candidate, Zofin is an acellular, biologic therapeutic that is naturally derived and manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance. Zofin is in Phase I/II clinical trials to treat Long COVID and COPD. The company has entered an agreement with CDC to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection.

Statistics

Range Today

1.05 1.15

Volume Today 786

Range 1 Year

0.9 4.8

Volume 1 Year 847.94K

Range 3 Year

0.9 77.8

Volume 3 Year 3.88M

Range 10 Year

0.7 300

Volume 10 Year 7.14M

Highlights

Market Capitalization 16.85M (micro)

Floating Shares 3.6M

Current Price 1.15

Price To Earnings -0.01

Price To Revenue 3.37

Earnings Per Share -198

Payout Ratio 0%

Performance

Latest +13.86%

1 Month -42.5%

3 Months -5.74%

6 Months -36.11%

1 Year -52.08%

3 Years -98.08%

5 Years -82.44%

10 Years -70.44%

Benchmarks

Market Capitalization

331 / 368

Gross Profits

108 / 278

Total Revenue

202 / 300

Total Rank

220 / 368

Free Cashflow

67 / 352

Performance 5 years

239 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.